2 results
Approved WMOCompleted
To confirm the safety of the Articulinx implant by evaluating device and procedure related adverse events.
Not approvedWill not start
The primary objective of this study is to compare the overall survival (OS) associated with rAd-IFN, when administered with celecoxib and gemcitabine, versus that associated with celecoxib and gemcitabine alone for the treatment of patients with MPMā¦